Connect with us

Health

As the U.S. Exits Foreign Aid, Who Will Fill the Gap?

Published

on

As the U.S. Exits Foreign Aid, Who Will Fill the Gap?

As the reality sets in that the United States is drastically diminishing its foreign assistance to developing countries, an urgent conversation is starting among governments, philanthropists, and global health and development organizations.

It is centered on one crucial question: Who will fill this gap?

Last year, the United States contributed about $12 billion to global health, money that has funded treatment of H.I.V. and prevention of new infections; children’s vaccines against polio, measles and pneumonia; clean water for refugees; and tests and medications for malaria.

The next largest funder is the Gates Foundation, which disburses a fraction of that amount: its global health division had a budget of $1.86 billion in 2023.

“The gap that has been filled by the U.S. cannot be easily matched by anybody,” said Dr. Ntobeko Ntusi, the chief executive of the South African Medical Research Council.

Advertisement

U.S. assistance has been channeled through the United States Agency for International Development, or U.S.A.I.D., which the new Trump administration has largely dismantled, and other government agencies, including the National Institutes of Health, which is also facing substantial cuts in health research grants.

Many people are suggesting that other countries, particularly China, could move into some of the areas vacated by the United States, Dr. Ntusi said. Others are making urgent appeals to big philanthropies including the Gates Foundation and Open Philanthropy.

This conversation is most consequential in Africa. About 85 percent of U.S. spending on global health went to programs in or for African countries.

For countries such as Somalia, where U.S. aid made up 25 percent of the government’s whole budget, or Tanzania, where the U.S. funded a majority of public health care, the loss is catastrophic. And for the major global health agencies, the situation is similarly critical.

President Trump has already pulled the U.S. out of the World Health Organization, which is now trying to make an initial budget cut of $500 million for 2026-27 to cope with the withdrawal of American funds.

Advertisement

Most of our neighbors on the continent, they’ve been completely reliant on the U.S. to procure most of the lifesaving medications for endemic infections,” Dr. Ntusi said. “And I don’t see most of the governments overnight being able to have the resources to cope. And so I think there’s going to be devastating consequences on lives lost from Africans who will die of preventable infections”

The U.S. is the largest donor to Gavi, an organization that supplies essential vaccines to the world’s poorest countries, and to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The U.S. contribution is required by Congress. Asked about the commitment to these and other multilateral agencies including the Pandemic Fund, a State Department spokesperson said that the programs were being reviewed to see if they aligned with the national interest, and that funding would continue only for those that met this condition.

There is no indication that additional funding will come from the other G7 countries, the European Union or other high-income nations. Britain, Germany, France, the Netherlands and Scandinavian countries have all reduced their foreign aid. Some new donor countries have come forward to support the W.H.O., including Saudi Arabia and South Korea, but their spending is dwarfed by the amount the U.S. once gave.

Of nongovernmental players, the World Bank is best placed to provide long-term support for health spending. The bank has said little so far. It could offer countries hit hard by the U.S. cutoff innovative financing such as debt-for-health-care swaps to give nations struggling under heavy debt burdens some fiscal freedom to make up lost health care funding. However, the U.S. is the largest shareholder of the bank, and the Trump administration would have influence over any such investment.

Much of the public discussion about filling the vacuum left by the U.S. has focused on China, which has built a significant presence by financing infrastructure projects in African countries, particularly those with extensive mineral reserves or strategic ports.

Advertisement

“There is good reason for them to do so,” said Ja Ian Chong, an associate professor of political science at the National University of Singapore. China regards foreign aid as a soft-power tool in its superpower rivalry with the United States, much as the United States did when setting up U.S.A.I.D. during the height of the Cold War with the Soviet Union. China seeks to use aid to garner more support from developing countries in the United Nations.

While Chinese aid has largely come in loans to build infrastructure, it includes support for more varied projects. China’s answer to Western development aid, a program unveiled in 2021 called the Global Development Initiative, includes $2 billion for upgrading livestock production in Ethiopia, fighting malaria in Gambia and planting trees in Mongolia, among other projects.

Mr. Chong said China’s ability to fill the opening left by U.S.A.I.D. could be constrained by its own financial limitations. China’s economy has stagnated because of a property crisis and rising government debt, and the country has already scaled back on big infrastructure loans.

To date, China has shown little interest in supporting global health programs, or in providing grants on a scale anywhere near U.S.A.I.D. levels. AidData, a university research lab at William & Mary in Virginia, estimates that Beijing provides about $6.8 billion a year in grants and low-cost loans.

Philanthropies that were already working in global health have been deluged with panicked calls from organizations with frozen funds.

Advertisement

I have talked to some foundations who have all said we’re being inundated with people saying, ‘Help us, help us, help us,’ and I think they’re trying to patch little holes,” said Sheila Davis, the chief executive of the nonprofit Partners in Health, which works with local governments to bring health care to communities in developing countries. But if a patchwork bailout can cover just 20 percent of what the U.S. was paying for, what should a new donor save? she asked. “Do you choose to save one program fully and then let others go? Or what is the best strategy?”

Chief among the foundations fielding pleas for help is the Gates Foundation, which has been warning its grant recipients that it cannot make up the gap. In addition to funding global health programs, the foundation also supports health research and is a major contributor to Gavi.

“There is no foundation — or group of foundations — that can provide the funding, work force capacity, expertise, or leadership that the United States has historically provided to combat and control deadly diseases and address hunger and poverty around the world,” the foundation’s North America director, Rob Nabors, said by email.

Multiple recipients of Gates Foundation funding, who declined to speak on the record because they were describing confidential conversations, said they had been told by foundation staff members that it would continue to fund research and programs in the areas it already worked, but wouldn’t expand significantly, and that while some grants might be restructured to try to compensate for part of the lost U.S. funding, the foundation’s work would continue to be “catalytic” rather than support large-scale programming like U.S.A.I.D. did.

John-Arne Røttingen, the chief executive of the Wellcome Trust, which is among the largest donors to global health research, said in an email that the foundation was “exploring what options might exist” in the new landscape. But, he said, its help would be “a drop in the ocean compared to what governments across the world need to provide.”

Advertisement

A couple of small organizations, such as Founders Pledge, have started “bridge funds,” ranging from about $20 million to $200 million, to try to help plug immediate gaps.

But the philanthropic sector has largely been silent about the momentous change in the landscape. Major players that have already put hundreds of millions of dollars into health care in Africa, such as the Susan T. Buffett Foundation, did not respond to questions about their plans. The Delta Foundation (co-founded by the Zimbabwean telecom billionaire Strive Masiyiwa) declined to discuss the issue.

Two executives at smaller private foundations said there was a reluctance to say anything publicly because of fear of retribution from the Trump administration, including a potential loss of charitable status.

African governments are under tremendous pressure from frustrated citizens to assume responsibility for the health spending that was coming from the U.S. The issue led the agenda at a meeting of the continent’s health ministers at an African Union summit last week.

In the 24 years since the Union adopted what’s called the Abuja Declaration, committing its 42 members to spending 15 percent of their budgets on health, only a couple of states have ever hit that target, and for a year or two at most. Average health spending by African countries is less than half that amount.

Advertisement

In Nigeria, the president convened an emergency cabinet committee to make a plan for the budget shortfall, and Parliament allotted an extra $200 million to the national budget last week. But that extraordinary measure illustrates the scale of what’s been lost: it’s less than half of the $512 million that the U.S. gave Nigeria for health care in 2023.

Nigeria’s health minister, Dr. Muhammad Pate, said that nearly 28,000 health care workers in the country had been paid in whole or part by U.S.A.I.D., which also covered three-quarters of the bill for drugs and test kits for the 1.3 million Nigerians who live with H.I.V.

Nigeria will quickly need to find new ways of operating, he said, including boosting manufacturing of some of those items domestically. “It may not be as fancy, but at least it will serve,” Dr. Pate said.

He also predicted that the end of U.S. aid would accelerate what he called a “realignment” in Africa. “The world has shifted in the last 20 years,” he said. “So we have other actors: We have China, India, Brazil, Mexico and others.”

Deisy Ventura, a professor of global health ethics at the University of São Paulo, said the change could open opportunities for other countries to exert newfound influence.

Advertisement

“The retreat of the United States may open space for new leaders now,” she said. “It’s important for us in the global south to imagine an international coordination of emergency preparedness and response without the United States.”

Berry Wang contributed reporting from Hong Kong.

Health

Vision problem leads to man’s stage 4 lung cancer diagnosis, new drug extends survival

Published

on

Vision problem leads to man’s stage 4 lung cancer diagnosis, new drug extends survival

NEWYou can now listen to Fox News articles!

A former Ironman triathlete was stunned to learn that his vision problems were actually the first sign of stage 4 lung cancer.

Dave Nitsche, 57, was initially given just 12 to 24 months to live – but a newly approved drug has helped him surpass that timeframe by several years.

“In 2019, I noticed that I was having trouble seeing with my left eye,” the Canadian man shared during an interview with Fox News Digital. “I went to the optometrist, and they said it was probably a detached retina.”

DOCTOR AND CANCER SURVIVOR GEARS UP TO RUN 7 MARATHONS ON 7 CONTINENTS IN 7 DAYS

Advertisement

After scans revealed fluid buildup and rising pressure, doctors determined that Nitsche had lost vision in the eye — and ultimately removed it. A biopsy of the fluid revealed that it was cancerous.

Next, Nitsche saw more specialists, who extracted fluid from his lungs for more testing. “The next day, the oncologist told me that I had stage 4 lung cancer,” he said. 

Dave Nitsche, pictured in Calgary, Alberta in 2025, was stunned to learn that his vision problems were actually the first sign of stage 4 lung cancer. (Dave Nitsche)

Nitsche said his doctors were “very shocked” to find that his initial eye issues had stemmed from lung cancer – particularly because he had never been a smoker.

Azam J. Farooqui, M.D., a hematology and oncology physician at Ironwood Cancer & Research Centers in Chandler, Arizona, agreed that Nitsche’s case was “very surprising.”

Advertisement

LUNG CANCER RISING AMONG NON-SMOKERS — HERE’S WHY

“Cancer can find its way to some very odd locations, but the eye is a very, very rare one,” Farooqui, who did not treat Nitsche, told Fox News Digital. “Usually cancer will get there via a nerve channel or blood vessel, but it’s very uncommon.”

Nitsche, an ex-triathlete who has done multiple Ironman races, hadn’t experienced any other symptoms other than the eye issues. “I was running quite a bit at the time,” he shared. “I had a little bit of back pain here and there, but lung cancer definitely wasn’t on my radar.”

Nitsche, an ex-triathlete who has done multiple Ironman races, hadn’t experienced any other symptoms other than the eye issues. “I had a little bit of back pain here and there, but lung cancer definitely wasn’t on my radar.” (Dave Nitsche)

His first treatment was a targeted therapy called afatinib, which lasted about three months. When doctors found that the cancer had spread to Nitsche’s brain, he began taking another medication called Tagrisso (osimertinib), which crosses the blood-brain barrier.

Advertisement

HIDDEN FACTOR IN CANCER TREATMENT TIMING MAY AFFECT SURVIVAL, RESEARCHERS SAY

After six years, when those drugs stopped working, Nitsche started taking Rybrevant (amivantamab), a chemo-free drug that he receives via IV infusion every three weeks in a supervised medical setting. After a year on the drug, which is developed by Johnson & Johnson, his scans are looking “very, very good,” he said.

“There are days that you feel strong and there are days that you’re a little weaker, but you just adjust accordingly.”

“Science is catching up to me perfectly with all these drugs that I’m on,” Nitsche said. “Now, we’ll just wait for the next thing to come along, and we’ll jump onto that. But for now, the Rybrevant is working perfectly.”

Nitsche has experienced a few side effects, but said for the most part, the drug he is taking is “very tolerable.” (Dave Nitsche)

Advertisement

Nitsche has experienced a few side effects, primarily skin irritation and fingernail infections, but said for the most part, the drug is “very tolerable.”

Compared to the full-dose chemo and other lung cancer treatments, Farooqui agreed that Rybrevant is “very manageable.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Other common side effects can include infusion reactions, muscle and joint pain, mouth sores, swelling, fatigue, nausea, bowel changes, vomiting, cough, shortness of breath and low appetite, according to FDA prescribing information.

In rare cases, serious effects can include lung inflammation, blood clots, severe skin reactions and eye problems. Pregnant women should not take the drug due to fetal risks.

Advertisement

Embracing his role as an advocate, Nitsche now speaks openly about his experience and what others should know. (Dave Nitsche)

“If somebody is having too many side effects, or if it is feeling too aggressive, we can do dose reductions,” Farooqui noted. “In my experience, we’ve had patients do really well on it, and we’ve been able to manage their side effects without any major concerns.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Rybrevant has now been approved to treat certain types of non-small cell lung cancer in the U.S. and Canada, and Nitsche said a few of his friends are also taking the drug.

“Doctors gave me a year to two years – they told me to get my affairs in order. And it’s been seven years now,” he said. “I’ll take it.”

Advertisement

“For almost any type of cancer, a diagnosis is not a death sentence.”

Nitsche is now preparing for a 600-mile biking expedition in June to raise awareness for lung cancer. He credits his endurance training and high fitness level with helping to extend his survival. 

“There are days that you feel strong and there are days that you’re a little weaker, but you just adjust accordingly,” he said.

Rybrevant has now been approved to treat certain types of non-small cell lung cancer in the U.S. and Canada. (iStock)

Embracing his role as an advocate, Nitsche now speaks openly about his experience and what others should know.

Advertisement

“If you have lungs, you can get lung cancer – but at this point, for almost any type of cancer, a diagnosis is not a death sentence,” he said. “They’re doing so much research on it, especially with lung cancer… I’ve known people who have lasted 12 to 18 years, so for me, seven years is great. So I’ll just keep going.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Farooqui echoed the importance of patients “advocating for themselves and getting the most up-to-date therapy there is.”

Continue Reading

Health

Jane Seymour, 75, shares how she approaches aging with vitality: ‘Best I can be’

Published

on

Jane Seymour, 75, shares how she approaches aging with vitality: ‘Best I can be’

NEWYou can now listen to Fox News articles!

At 75, Jane Seymour isn’t fighting the years under her belt — she’s leaning into them. The former Bond girl in “Live and Let Die” and star of “Dr. Quinn, Medicine Woman” has a simple outlook on aging: She’s just grateful for the opportunity.

Her perspective shifted radically in her 40s after a near-death experience involving anaphylactic shock, according to an interview the actress did with Women’s Health.

“I remember looking at my body from above and thinking, ‘That’s your vehicle. I am responsible for taking care of this car,’” Seymour recalled.

COMMON EATING HABIT MAY TRIGGER PREMATURE IMMUNE SYSTEM AGING, STUDY FINDS

Advertisement

The actress shared the following four key habits she uses to navigate her 70s with vitality.

1. Embrace a positive attitude

Seymour’s perspective shifted in her 40s after a near-death experience involving anaphylactic shock, she told Women’s Health. (Michael Loccisano/Getty Images for Elton John AIDS Foundation)

For Seymour, the mental game of aging is just as important as the physical. She said she approaches every day with a sense of optimism, which she describes as “getting up and not giving up.”

In a recent interview with Future of Personal Health, Seymour said that being depressed over lost youth is “redundant.” Instead of mourning the past, she embraces the present.

EXPERTS REVEAL WHY ‘NONNAMAXXING’ TREND MAY IMPROVE MENTAL, PHYSICAL HEALTH

Advertisement

“You were 20, and you had whatever that experience was,” she said. “Now, maybe you’re 70, and it’s a whole new world.”

2. Know your body

Seymour’s fitness routine is built on consistency rather than intensity, she shared. The actress aims to work out at least three times a week, but refuses to push herself to the point of injury.

“You were 20, and you had whatever that experience was,” she said. “Now, maybe you’re 70, and it’s a whole new world.” (Jane Seymour/Instagram)

“I listen to my body,” she told Women’s Health. “I’m not going to overdo it.”

Seymour’s workouts focus on strengthening her core, arms and legs. While her preference is the reformer (a Pilates machine), she is highly adaptable.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

When traveling without workout equipment, Seymour said she performs bodyweight exercises, even doing incline press-ups against a kitchen counter.

“I’m not going to pretend I’m 20 when I’m 70,” she said. “I’m going to be the best I can be at the age I am.”

3. Nourish your body

Rather than fighting the natural signs of a life well-lived, Seymour said she views her appearance as a professional asset.

Seymour focuses on a rigorous skincare and nutritional routine to maintain the “vehicle” she was given, she said. (Emma Mcintyre/Getty Images)

Advertisement

“I’m not chasing wrinkles,” she added. “My laugh lines and even my frown lines are useful in my work – they’re part of my toolkit.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The actress said she focuses on a rigorous skincare and nutritional routine to maintain the “vehicle” she was given.

CLICK HERE FOR MORE HEALTH STORIES

This includes a daily regimen of exfoliation and hydration, alongside a diet rich in fruits and vegetables.

Advertisement

“I’m going to be the best I can be at the age I am.”

When her filming schedule makes fresh meals difficult, Seymour supplements with antioxidant blends to ensure there are “no nutritional gaps,” aiming for a holistic balance that allows her to “think sharper and move stronger.”

4. Nourish your mind

Perhaps the most profound tool in Seymour’s toolkit, she said, is her commitment to purpose. Inspired by her mother, a survivor of WWII concentration camps, Seymour believes that longevity is tied to how much one gives back to the world.

Seymour, inspired by her mother, a survivor of WWII concentration camps, created Open Hearts Foundation to give back to the community. (Jane Seymour/Instagram)

“My mother always said there’s someone worse off than you, and you can find purpose by helping others – listening and making them feel heard,” she shared.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

This philosophy led Seymour to found the Open Hearts Foundation, a nonprofit that empowers others through grant-making and volunteerism.

“That’s the best way to end the day — knowing it wasn’t wasted.”

Continue Reading

Health

The Menopause Diet 5-Day Plan To Lose Weight Helps Women Drop Pounds Fast

Published

on

The Menopause Diet 5-Day Plan To Lose Weight Helps Women Drop Pounds Fast


Advertisement





The Menopause Diet 5-Day Plan To Lose Weight After 50




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending